These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19039226)
1. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study. Olazarán J; Cruz I; Benito-León J; Morales JM; Duque P; Rivera-Navarro J Eur Neurol; 2009; 61(2):87-93. PubMed ID: 19039226 [TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
3. Cognitive functioning in children with multiple sclerosis. Montiel-Nava C; Peña JA; González-Pernía S; Mora-La Cruz E Mult Scler; 2009 Feb; 15(2):266-8. PubMed ID: 18922833 [TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
5. [Language abnormalities in patients with multiple sclerosis]. Drake MA; Allegri RF; Carrá A Neurologia; 2002 Jan; 17(1):12-6. PubMed ID: 11834193 [TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in different MS subtypes and clinically isolated syndromes. Potagas C; Giogkaraki E; Koutsis G; Mandellos D; Tsirempolou E; Sfagos C; Vassilopoulos D J Neurol Sci; 2008 Apr; 267(1-2):100-6. PubMed ID: 17997417 [TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms. Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264 [TBL] [Abstract][Full Text] [Related]
9. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173 [TBL] [Abstract][Full Text] [Related]
10. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis. Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689 [TBL] [Abstract][Full Text] [Related]
11. [Cognitive functions in multiple sclerosis]. Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country. Cáceres F; Vanotti S; Rao S; J Clin Exp Neuropsychol; 2011 Dec; 33(10):1094-8. PubMed ID: 21978317 [TBL] [Abstract][Full Text] [Related]
13. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. Portaccio E; Goretti B; Lori S; Zipoli V; Centorrino S; Ghezzi A; Patti F; Bianchi V; Comi G; Trojano M; Amato MP; Mult Scler; 2009 May; 15(5):620-6. PubMed ID: 19318511 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311 [TBL] [Abstract][Full Text] [Related]
15. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822 [TBL] [Abstract][Full Text] [Related]
16. An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis. Koutsis G; Panas M; Giogkaraki E; Karadima G; Sfagos C; Vassilopoulos D Mult Scler; 2009 Feb; 15(2):174-9. PubMed ID: 18805838 [TBL] [Abstract][Full Text] [Related]
17. Antisaccade performance in patients with multiple sclerosis. Fielding J; Kilpatrick T; Millist L; White O Cortex; 2009; 45(7):900-3. PubMed ID: 19327763 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis. Woolmore J; Stone M; Holley S; Jenkinson P; Ike A; Jones P; Fryer A; Strange R; Stephens R; Langdon D; Hawkins C Mult Scler; 2008 Mar; 14(2):177-82. PubMed ID: 17942526 [TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study. Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313 [TBL] [Abstract][Full Text] [Related]
20. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables]. Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]